Maximal androgen blockade in advanced prostate cancer

被引：0
|
作者：
Wolff, JM [1 ]
Heine, K [1 ]
机构：
[1] Caritas Krankenhaus, Urol Klin, D-97980 Bad Mergentheim, Germany
来源：
UROLOGE | 2005年 / 44卷 / 11期
关键词：
D O I：
10.1007/s00120-005-0949-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1346 / 1350
页数：5
相关论文
共 50 条
  • [41] TOTAL ANDROGEN BLOCKADE FOR METASTATIC CANCER OF PROSTATE
    BELAND, G
    ELHILALLI, MM
    FRADET, Y
    LAROCHE, B
    RAMSEY, EW
    TRACHTENBERG, J
    VENNER, PN
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (08): : 1233 - 1233
  • [42] TOTAL ANDROGEN BLOCKADE FOR METASTATIC CANCER OF THE PROSTATE
    BELAND, G
    ELHILALI, M
    FRADET, Y
    LAROCHE, B
    RAMSEY, EW
    TRACHTENBERG, J
    VENNER, PM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 : S187 - S190
  • [43] TOTAL ANDROGEN BLOCKADE FOR METASTATIC CANCER OF PROSTATE
    BELAND, G
    ELHILALLI, MM
    FRADET, Y
    LAROCHE, B
    RAMSEY, EW
    TRACHTENBERG, J
    VENNER, PN
    JOURNAL OF UROLOGY, 1987, 137 (04): : A254 - A254
  • [44] LEUPROLIDE PLUS FLUTAMIDE - COMBINED ANDROGEN BLOCKADE IN THE TREATMENT OF ADVANCED PROSTATE-CANCER
    CHODOFF, L
    MOUNT SINAI JOURNAL OF MEDICINE, 1990, 57 (03): : 171 - 173
  • [45] Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: The argument against
    Fitzpatrick, JM
    EUROPEAN UROLOGY, 1996, 29 : 37 - 39
  • [46] Combined androgen blockade is underused in advanced prostate cancer: Findings from an international survey
    Castro-Diaz, D.
    Gillatt, D.
    Payne, H.
    Akaza, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 86 - 86
  • [47] Comparison of goserelin and leuprolide in combined androgen blockade (CAB) for advanced prostate cancer.
    Sarosdy, MF
    Schellhammer, PF
    Block, NL
    Soloway, MS
    Venner, PM
    Patterson, AL
    Sharifi, R
    Vogelzang, NJ
    Chodak, GW
    Klein, EA
    Schellenger, JJ
    Kolvenbag, GJCM
    JOURNAL OF UROLOGY, 1998, 159 (05): : 338 - 338
  • [48] Intermittent androgen blockade or continuous androgen blockade in advanced prostate cancer: a meta-analysis of efficacy, quality of life and side effects
    Zhu, Jianguo
    Wang, Yunlin
    Xu, Shuxiong
    Sun, Zhaolin
    JOURNAL OF BUON, 2012, 17 (02): : 350 - 356
  • [49] Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer
    Galvao, Daniel A.
    Spry, Nigel A.
    Taaffe, Dennis R.
    Newton, Robert U.
    Stanley, John
    Shannon, Tom
    Rowling, Chris
    Prince, Richard
    BJU INTERNATIONAL, 2008, 102 (01) : 44 - 47
  • [50] Efficacy of maximal androgen blockade versus castration alone in the treatment of advanced prostate cancer: a retrospective clinical experience from a Chinese medical centre
    Chen, Xue-Qin
    Huang, Ying
    Li, Xiang
    Zhang, Peng
    Huang, Rui
    Xia, Juan
    Chen, Ni
    Wei, Qiang
    Zhu, Yu-Chun
    Yang, Yu-Ru
    Zeng, Hao
    ASIAN JOURNAL OF ANDROLOGY, 2010, 12 (05) : 718 - 727
12345